Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Sale of 731 CBIO shares, $13.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | CRESCENT BIOPHARMA, INC. (CBIO) | Sale | 731 | $13.1K |
| Jun 23, 2026 | CRESCENT BIOPHARMA, INC. (CBIO) | Sale | 20,549 | $369.7K |
| Dec 17, 2025 | CRESCENT BIOPHARMA, INC. (CBIO) | Grant/Award | 19,507 | n/a |
| Dec 10, 2025 | CRESCENT BIOPHARMA, INC. (CBIO) | Grant/Award | 172,836 | n/a |
| Aug 20, 2024 | Dyne Therapeutics, Inc. (DYN) | Sale | 2,400 | $108.0K |
| Jun 11, 2024 | Dyne Therapeutics, Inc. (DYN) | Sale | 1,823 | $57.1K |
| May 18, 2024 | Dyne Therapeutics, Inc. (DYN) | Sale | 2,279 | $64.3K |
| Apr 5, 2024 | Dyne Therapeutics, Inc. (DYN) | Grant/Award | 35,000 | n/a |
| Mar 13, 2024 | Dyne Therapeutics, Inc. (DYN) | Exercise/Conversion | 86,159 | $477.3K |
| Mar 12, 2024 | Dyne Therapeutics, Inc. (DYN) | Sale | 2,434 | $62.9K |